Overview

• Novartis unveiled a $23 billion investment plan to build and expand 10 facilities across the United States over the next five years.
• The expansion includes six new manufacturing plants and a research and development site in San Diego, California.
• The project is expected to generate over 4,000 jobs, including 1,000 skilled positions and 3,000 construction and support roles.
• The move aligns with Novartis' U.S.-first strategy to produce drugs domestically and strengthen its position in the U.S. pharmaceuticals market.
• While the decision considers proposed pharmaceutical import tariffs by President Trump, Novartis emphasized that tariffs are not the primary driving factor.